Katı Kişi Sendromu, Bir Olgu

Stiff-person syndrome (SPS) is an autoimmune disease emerged by lack of inhibition to excitatory neurotransmitters in the central neurveus system often due to antibodies against glutamic acid decorboxylase (GAD). Fluctuating and progresive muscle rigidity, spasms and also stiffness are common manifestations. The pathophysiology of SPS is not fully understood but however, high titres of anti-GAD antibodies are strongly associated with this syndrome and immunological treatment helps to improve the rigidity, painfully spasms and stiffness. Here we present a case of a 61 years old female patient diagnosed with positive anti-GAD65 antibodies SPS. In the context of a severely disabling disease manifestation, we analyse the case presentation and treatment strategies.A 61-year-old female patient pesented with recent falls, muscle contractions and pain in the lower extremities. Neurological examination revealed severe rigidity and painfull spasms of the lower extremities and reactive spasms to touch were present. Full blood count, routine biochemistry, CSF analyze were normal. Electromyography (EMG) demonstrated a continuous motor unit activity of whole lower extremity muscles. According to EMG findings our preliminary diagnosis was Stiff Person Syndrome. Anti-GAD antibodies were detected positive. This finding reinforced the diagnosis of anti-GAD-associated stiffperson syndrome. Diazepam, clonazepam, plasmapheresis and alsointaveneus immun globulin was administered step by step. She did not get any significant benefit from any of treatments. Treatment with rituximab was planned but the patient was admitted to the intensive care unit due to pulmonary embolism and respiratory distress caused by COVID infection. Unfortunately, Rituximab could not be administered due to the patient's poor general condition.SPS remains an important consideration in the differential diagnosis of muscle stiffness. It is important to perform. Detailed investigations are essential to determine whether an underlying cause exists.

Authors

Publication Details

Journal
DergiPark (Istanbul University)
Published
2025-05-22
Primary Topic
Shoulder Injury and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Katı Kişi Sendromu, Bir Olgu

Şeniz Akçay Yalbuzdağ, Buğra İnce, Neslihan Eşkut, Fikriye Elif Saka et al.
DergiPark (Istanbul University)
Shoulder Injury and Treatment
article

Katı Kişi Sendromu, Bir Olgu

Şeniz Akçay Yalbuzdağ, Buğra İnce, Neslihan Eşkut, Fikriye Elif Saka, Aslı Köşkderelioğlu, Gizemnur Filinta
article en

Abstract

Stiff-person syndrome (SPS) is an autoimmune disease emerged by lack of inhibition to excitatory neurotransmitters in the central neurveus system often due to antibodies against glutamic acid decorboxylase (GAD). Fluctuating and progresive muscle rigidity, spasms and also stiffness are common manifestations. The pathophysiology of SPS is not fully understood but however, high titres of anti-GAD antibodies are strongly associated with this syndrome and immunological treatment helps to improve the rigidity, painfully spasms and stiffness. Here we present a case of a 61 years old female patient diagnosed with positive anti-GAD65 antibodies SPS. In the context of a severely disabling disease manifestation, we analyse the case presentation and treatment strategies.A 61-year-old female patient pesented with recent falls, muscle contractions and pain in the lower extremities. Neurological examination revealed severe rigidity and painfull spasms of the lower extremities and reactive spasms to touch were present. Full blood count, routine biochemistry, CSF analyze were normal. Electromyography (EMG) demonstrated a continuous motor unit activity of whole lower extremity muscles. According to EMG findings our preliminary diagnosis was Stiff Person Syndrome. Anti-GAD antibodies were detected positive. This finding reinforced the diagnosis of anti-GAD-associated stiffperson syndrome. Diazepam, clonazepam, plasmapheresis and alsointaveneus immun globulin was administered step by step. She did not get any significant benefit from any of treatments. Treatment with rituximab was planned but the patient was admitted to the intensive care unit due to pulmonary embolism and respiratory distress caused by COVID infection. Unfortunately, Rituximab could not be administered due to the patient's poor general condition.SPS remains an important consideration in the differential diagnosis of muscle stiffness. It is important to perform. Detailed investigations are essential to determine whether an underlying cause exists.

DergiPark (Istanbul University)
Openalex Percentile: Top 55%
Shoulder Injury and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.